azimilide has been researched along with Recrudescence in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Connolly, SJ; Marcello, SR; Page, RL; Pritchett, EL; Schnell, DJ; Wilkinson, WE | 2 |
Al-Khalidi, H; Brum, J; Henthorn, R; Holroyde, M; Niazi, I; Simmons, T; Singer, I; Tchou, P | 1 |
Clemett, D; Markham, A | 1 |
2 trial(s) available for azimilide and Recrudescence
Article | Year |
---|---|
Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chest Pain; Dizziness; Double-Blind Method; Dyspnea; Fatigue; Heart Rate; Humans; Hydantoins; Imidazoles; Imidazolidines; Piperazines; Recurrence | 2003 |
Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators.
Topics: Aged; Anti-Arrhythmia Agents; Defibrillators, Implantable; Double-Blind Method; Female; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Pilot Projects; Piperazines; Recurrence; Tachycardia, Ventricular | 2004 |
2 other study(ies) available for azimilide and Recrudescence
Article | Year |
---|---|
Azimilide.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Headache; Humans; Hydantoins; Imidazoles; Imidazolidines; Piperazines; Recurrence; Torsades de Pointes | 2000 |
Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Comorbidity; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Hydantoins; Imidazoles; Imidazolidines; Male; Middle Aged; Myocardial Ischemia; Piperazines; Randomized Controlled Trials as Topic; Recurrence | 2001 |